Monte Rosa Therapeutics, Inc. earnings per share and revenue

GLUE earnings per share for the last quarter are 0.16 USD whereas the estimation was 0.02 USD which accounts for 929.07% surprise. Company revenue for the same period amounts to 60.62 M USD despite the estimated figure of 46.67 M USD. Estimated earnings per share for the next quarter are -0.40 USD, and revenue is expected to reach 11.63 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.